tiprankstipranks
Trending News
More News >
Emami Limited (IN:EMAMILTD)
:EMAMILTD
India Market
Advertisement

Emami Limited (EMAMILTD) AI Stock Analysis

Compare
0 Followers

Top Page

IN:EMAMILTD

Emami Limited

(EMAMILTD)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
₹627.00
▲(12.40% Upside)
Emami Limited's strong financial performance is the primary driver of its stock score, reflecting robust revenue growth and profitability. However, the technical analysis indicates a bearish trend, and the high P/E ratio suggests the stock may be overvalued, which tempers the overall score. The absence of earnings call insights and corporate events means these factors did not influence the score.

Emami Limited (EMAMILTD) vs. iShares MSCI India ETF (INDA)

Emami Limited Business Overview & Revenue Model

Company DescriptionEmami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; balm, balm ultra-power, quick relief roll-on, ortho vedic oil, healthcare products, pancharishta, nityam, kesari jivan, and ayurvedic hand sanitizers under the Zandu brand; radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products under the Kesh King brand; pain reliever balm under the Mentho Plus brand; and pain relief ointment under the Fast Relief brand. The company also offers prickly heat powder under the Dermicool brand; non sticky hair oil under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; home hygiene solutions under the Emasol brand; and normal, dry, and ultra-dry skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
How the Company Makes MoneyEmami Limited generates revenue through the sale of its wide array of personal care and healthcare products, primarily targeting the mass consumer market. The company’s revenue model is anchored in its extensive distribution network, which spans across urban and rural areas, ensuring a broad reach for its products. Key revenue streams include the sales of skincare products, hair oils, and OTC healthcare products, with significant contributions from established brands like Boroplus and Navratna. Emami also capitalizes on strategic marketing and brand endorsements to strengthen its market position. Additionally, the company benefits from strategic partnerships and collaborations for product innovation and expansion into new markets, which further bolster its earnings.

Emami Limited Financial Statement Overview

Summary
Emami Limited demonstrates impressive financial health with robust revenue growth, strong profitability margins, and effective debt management. The company's consistent performance in generating free cash flow and maintaining a high equity ratio underlines its financial stability and operational efficiency. While slight concerns exist regarding fluctuating net income and increasing liabilities, the overall trajectory remains positive, reflecting a well-managed business poised for continued success.
Income Statement
85
Very Positive
Emami Limited has shown a consistent increase in revenue over the years, with a notable revenue growth rate of 6.45% from 2024 to 2025. The company maintains a strong gross profit margin of 68.64% and a net profit margin of 21.17% in 2025, indicating efficient cost management and profitability. The EBIT and EBITDA margins of 38.70% and 26.52% respectively, further highlight the company's strong operational performance. However, the decline in net income from 2022 to 2023 poses a slight concern for sustained profitability.
Balance Sheet
78
Positive
The balance sheet reflects a solid equity base with an equity ratio of 76.26% in 2025, emphasizing financial stability. The debt-to-equity ratio is low at 0.03, showcasing prudent debt management. Return on equity (ROE) is strong at 29.92%, indicating effective use of shareholder funds to generate profit. A notable strength is the reduction in total debt over the years, though the increase in total liabilities from 2024 to 2025 may warrant monitoring.
Cash Flow
82
Very Positive
The cash flow statement highlights a robust free cash flow growth rate of 15.28% from 2024 to 2025, driven by increased operating cash flow. The operating cash flow to net income ratio of 1.11 indicates healthy cash generation relative to reported profits. The free cash flow to net income ratio of 1.06 suggests strong cash conversion, although the consistent negative investing and financing cash flows could imply ongoing capital investments and debt repayments.
BreakdownTTMDec 2025Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue38.09B38.09B35.78B34.06B31.58B28.81B
Gross Profit24.59B26.15B23.78B22.04B20.58B19.34B
EBITDA10.60B10.10B9.90B9.14B10.41B9.53B
Net Income8.06B8.06B7.24B6.40B8.39B4.55B
Balance Sheet
Total Assets35.34B35.34B32.80B31.10B30.57B25.20B
Cash, Cash Equivalents and Short-Term Investments6.97B8.26B4.09B3.69B1.83B4.46B
Total Debt897.80M897.80M939.56M905.10M2.82B1.01B
Total Liabilities8.40B8.40B8.22B7.97B9.83B7.58B
Stockholders Equity26.95B26.95B24.47B23.03B20.77B17.63B
Cash Flow
Free Cash Flow0.008.51B7.38B7.08B1.60B8.88B
Operating Cash Flow0.008.96B7.79B7.49B6.44B9.22B
Investing Cash Flow0.00-3.40B-2.05B-1.13B-2.35B-2.27B
Financing Cash Flow0.00-5.00B-5.63B-6.08B-4.02B-6.88B

Emami Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price557.85
Price Trends
50DMA
589.71
Negative
100DMA
588.52
Negative
200DMA
582.80
Negative
Market Momentum
MACD
-5.55
Positive
RSI
35.10
Neutral
STOCH
7.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EMAMILTD, the sentiment is Negative. The current price of 557.85 is below the 20-day moving average (MA) of 591.59, below the 50-day MA of 589.71, and below the 200-day MA of 582.80, indicating a bearish trend. The MACD of -5.55 indicates Positive momentum. The RSI at 35.10 is Neutral, neither overbought nor oversold. The STOCH value of 7.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:EMAMILTD.

Emami Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
153.21B46.846.12%0.25%10.63%7.53%
70
Outperform
193.62B20.2540.70%6.64%7.57%8.08%
68
Neutral
114.09B31.2218.07%1.12%1.59%-2.52%
66
Neutral
₹244.94B29.771.43%4.06%10.78%
66
Neutral
141.85B34.2317.88%0.24%8.41%-2.59%
66
Neutral
188.47B35.7916.40%1.02%1.99%10.81%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:EMAMILTD
Emami Limited
557.85
-194.67
-25.87%
IN:CASTROLIND
Castrol India Limited
195.75
-36.24
-15.62%
IN:CROMPTON
Crompton Greaves Consumer Electricals Ltd.
292.70
-119.88
-29.06%
IN:FINEORG
Fine Organic Industries Ltd.
4,626.60
-602.93
-11.53%
IN:JYOTHYLAB
Jyothy Labs Limited
310.70
-240.84
-43.67%
IN:ZYDUSWELL
Zydus Wellness Limited
481.55
79.97
19.91%

Emami Limited Corporate Events

Emami Limited Announces Virtual AGM and Annual Report Release
Aug 4, 2025

Emami Limited has announced the submission of its Integrated Annual Report for the financial year 2024-25, along with the Notice of its 42nd Annual General Meeting (AGM) scheduled for August 29, 2025. The AGM will be held virtually in compliance with regulatory guidelines, and shareholders will receive the report electronically. This move underscores Emami’s commitment to transparency and digital engagement with its stakeholders, aligning with modern corporate governance practices.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2025